Home › Cancro ovarico › Kentucky
Studi clinici su Cancro ovarico nello stato di Kentucky
25 studi su Cancro ovarico cercano partecipanti presso sedi nello stato di Kentucky.
Città nello stato di Kentucky
Testo ufficiale dello studio (inglese)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- University of Kentucky/Markey Cancer Center, Lexington
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT07001748Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
In reclutamentoFase 2
Tutte le età · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT05564377A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Baptist Health Lexington /ID# 275218, Lexington
- Norton Cancer Institute - St. Matthews /ID# 276173, Louisville
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 29 set 2026 · NCT06890338A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0251 - Norton Cancer Institute, Louisville
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 29 set 2026 · NCT05128825A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Baptist Health Lexington, Lexington
- Norton Women's and Children's Hospital, Louisville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07213804A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Baptist Health Lexington /ID# 278267, Lexington
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 22 set 2026 · NCT07059845Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Norton Cancer Institute, Louisville
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT05983432Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- St Elizabeth Healthcare, Edgewood
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 15 set 2026 · NCT07214779A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Norton Cancer Institute, Louisville
In reclutamentoFase 2
Età da 18 a 99 · Donne · Aggiornato il 15 set 2026 · NCT07023627Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- Norton Cancer Institute, St. Matthews Clinic, Louisville
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 14 set 2026 · NCT06787612FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Norton Cancer Institute Research, Louisville
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06303505A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- St. Elizabeth Healthcare, Edgewood
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT06774963A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Baptist Health Corbin, Corbin
- Baptist Health Lexington, Lexington
- Norton Hospital Pavilion and Medical Campus, Louisville
- e altri 5
In reclutamento
Età da 35 a 50 · Donne · Aggiornato il 7 ago 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Baptist Health Corbin, Corbin
- Commonwealth Cancer Center-Corbin, Corbin
- e altri 10
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 ago 2026 · NCT06580314A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- St. Elizabeth Medical Center, Edgewood
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT06161025Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Kentucky, Lexington
In reclutamentoFase 1/2
Età da 18 a 90 · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT06710756EXoPERT EMERALD Clinical Study
- Lexington VA Healthcare System, Lexington
- KCTL, Louisville
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 45 e oltre · Tutti i sessi · Aggiornato il 1 lug 2026 · NCT07186296A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
- St. Elizabeth Medical Center - Edgewood /ID# 272113, Edgewood
- Baptist Health Lexington /ID# 272211, Lexington
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 26 mag 2026 · NCT06682988Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- University of Kentucky Medical Center, Lexington
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 16 apr 2026 · NCT05659381Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
- University of Kentucky, Lexington
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 apr 2026 · NCT04779554Combination Therapy for Recurrent Ovarian Cancer
- UofL Health Brown Cancer Center, Louisville
In reclutamentoFase 1/2
Età 18 e oltre · Donne · Aggiornato il 19 mar 2026 · NCT05610735First in Human Study of TORL-1-23 in Participants With Advanced Cancer
- University of Kentucky Medical Center, Lexington
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 feb 2026 · NCT05103683A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- University of Kentucky Markey Cancer Center, Lexington
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 feb 2026 · NCT06778863cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Corbin, Corbin
- Baptist Hardin, Elizabethtown
- Baptist Lexington, Lexington
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 40 e oltre · Tutti i sessi · Aggiornato il 20 gen 2026 · NCT05366881Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- Markey Cancer Center, Lexington
In reclutamentoVolontari sani benvenuti
Età 24 e oltre · Donne · Aggiornato il 14 nov 2025 · NCT04473833Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.